TR201010859A2 - Tablet forms containing cefdinir. - Google Patents

Tablet forms containing cefdinir.

Info

Publication number
TR201010859A2
TR201010859A2 TR2010/10859A TR201010859A TR201010859A2 TR 201010859 A2 TR201010859 A2 TR 201010859A2 TR 2010/10859 A TR2010/10859 A TR 2010/10859A TR 201010859 A TR201010859 A TR 201010859A TR 201010859 A2 TR201010859 A2 TR 201010859A2
Authority
TR
Turkey
Prior art keywords
forms containing
tablet forms
cefdinir
containing cefdinir
tablet
Prior art date
Application number
TR2010/10859A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TR2010/09165A external-priority patent/TR201009165A2/en
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/10859A priority Critical patent/TR201010859A2/en
Priority to PCT/TR2011/000252 priority patent/WO2012060787A1/en
Publication of TR201010859A2 publication Critical patent/TR201010859A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, aktif ajan olarak sefdinir içeren farmasötik bileşimlere ve bu bileşimlerin hazırlanmasında kullanılacak bir üretim yöntemine ilişkindir.The present invention relates to pharmaceutical compositions comprising cefdinir as the active agent and a method of manufacture for the preparation of such compositions.

TR2010/10859A 2010-11-05 2010-12-24 Tablet forms containing cefdinir. TR201010859A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/10859A TR201010859A2 (en) 2010-11-05 2010-12-24 Tablet forms containing cefdinir.
PCT/TR2011/000252 WO2012060787A1 (en) 2010-11-05 2011-11-03 Oral dosage forms comprising cefdinir and carboxymethyl cellulose calcium

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2010/09165A TR201009165A2 (en) 2010-11-05 2010-11-05 Tablets containing cefdinir
TR2010/10859A TR201010859A2 (en) 2010-11-05 2010-12-24 Tablet forms containing cefdinir.

Publications (1)

Publication Number Publication Date
TR201010859A2 true TR201010859A2 (en) 2012-05-21

Family

ID=45607338

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/10859A TR201010859A2 (en) 2010-11-05 2010-12-24 Tablet forms containing cefdinir.

Country Status (2)

Country Link
TR (1) TR201010859A2 (en)
WO (1) WO2012060787A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014051532A1 (en) * 2012-09-28 2014-04-03 Bilgic Mahmut Pharmaceutical tablet formulations comprising cefdinir
CN114681414A (en) * 2020-12-28 2022-07-01 北京新领先医药科技发展有限公司 Cefdinir dispersible tablet pharmaceutical composition and preparation process thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836918B (en) 1982-09-30 1984-05-30 Fujisawa Pharmaceutical Co 7-substituted-3-vinyl-3-cephem compounds and processes for the production of the same
US20070160675A1 (en) * 1998-11-02 2007-07-12 Elan Corporation, Plc Nanoparticulate and controlled release compositions comprising a cephalosporin
US20050131079A1 (en) * 2003-12-10 2005-06-16 Pujara Chetan P. Cefdinir oral suspension
TR200909785A1 (en) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Pharmaceutical compositions containing cefdinir as the active agent.
WO2011078830A1 (en) * 2009-12-25 2011-06-30 Bilgic Mahmut Rapidly dispersing effervescent formulation
TR201001417A1 (en) * 2010-02-25 2011-09-21 Sanovel İlaç San. Ve Ti̇c. A. Ş. Cefdinir formulation with improved dissolution rate

Also Published As

Publication number Publication date
WO2012060787A1 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
JOP20180103B1 (en) PHARMACEUTICAL COMPOSITION of CARBETOCIN
UA111717C2 (en) ORAL INTRODUCTION AND METHYLNALTREXON LIPOPHILIC SALTS
MY166449A (en) Pharmaceutical composition of rosuvastatin calcium
EA201291211A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE
UA116889C2 (en) COMPOSITION COMPRISING A MIXTURE OF CD95-Fc ISOFORMS
MX2013002948A (en) Pharmaceutical and nutraceutical compositions of abscisic acid.
EA201300034A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IMATINIB OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, AND WAYS TO OBTAIN THEM
EA201200616A1 (en) DERIVATIVES 2-OXO-1-PIRROLIDININILIMIDAZOTHIAADIA ASOL
EA201590787A1 (en) SUBSTITUTED PYRIDOPYRAZINES AS SYK INHIBITORS
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
PH12014502856A1 (en) Solid pharmaceutical preparation containing levothyroxine
UA118562C2 (en) Cxcr7 receptor modulators
TR201009167A2 (en) Pharmaceutical granules containing cephalosporin.
CO6680629A2 (en) Compounds with antibacterial activity against clsotridium
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
TR201010859A2 (en) Tablet forms containing cefdinir.
GEP201706675B (en) Imidazo-triazine derivatives as pde10 inhibitors
MX2015005510A (en) Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof.
MX2014004210A (en) 2-oxo-piperidinyl derivatives.
TR201009166A2 (en) Production method for cefdinir-containing pharmaceutical composition
TR201009165A2 (en) Tablets containing cefdinir
TR200906506A2 (en) Solid dosage forms containing telmisartan.
TR201104864A2 (en) Water-soluble formulations containing dexketoprofen.
TR201109160A2 (en) New pharmaceutical compositions containing eplerenone.
EA201190243A1 (en) STABLE PHARMACEUTICAL COMPOSITION OF FLUDARABIN PHOSPHATE